international study Time trends in neural tube defects prevalence in relation to preventive strategies: an http://jech.bmjjournals.com/cgi/content/abstract/53/10/630 Updated information and services can be found at: Outcome measures-Prevalence rate ratios based on the annual rates, using the Poisson regression model. Results-During the study period a significant fall in prevalence rates for all NTD is present in Atlanta (USA), England and Wales, Hungary and Japan, and a significant rise in Norway and South America. After adjusting for the secular trends observed in the earlier years of the study, no significant trend can be attributed to preventive strategies. Data on NTD prevalence are supplemented with information on folate awareness among some of the populations studied. Conclusion-There is no evidence that, up to the middle of 1996, any change in time trend was attributable to the introduction of national folate supplementation policies. The possible eVectiveness of folate supplementation policies for the reduction of NTD clearly needs to be tried and studied for several more years. Considering that in the Western world about 50% of pregnancies are unplanned, a policy that rests on action taken before conception can only have limited success. Strategies based on food enrichment, such as was introduced in the USA from the beginning of 1998, may prove to be more successful. (J Epidemiol Community Health 1999;53:630-635) A possible link between folic acid deficiency and neural tube defects (NTD) in humans was first proposed by Hibbard and Smithells.
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Throughout the 1980s, a number of observational and intervention studies gave strong support to the hypothesis that folic acid supplements, either alone or in multivitamin preparations, could prevent a high proportion of NTD if taken before and during early pregnancy. 2 3 The strongest support for the hypothesis came from two large, randomised studies. The UK Medical Research Council 4 showed that folic acid, 4 mg daily, gave significant protection against recurrences of NTD. Czeizel and Dudas 5 showed that a multivitamin preparation containing folic acid 0.8 mg protected against the first occurrence of NTD.
After these publications, government health departments in a number of countries began to consider how this new knowledge might be put to practical use by developing public health policies relating to folic acid supplementation.
The purpose of this study, which was carried out by the International Centre for Birth Defects (ICBD) in collaboration with the International Clearinghouse for Birth Defects Monitoring Systems (ICBDMS), was to examine time trends in NTD prevalence in relation to folic acid supplementation strategies in diVerent countries.
Methods
Our inquiries into the extent of folic acid supplementation were related to three questions: 1 Is there a national policy on folate supplementation? 2 If so, how eVectively is it being implemented? 3 Whether or not there is a national policy, what is actually happening? Are women being encouraged, by health personnel or the mass media, to increase their folic acid intake? How aware are women of folic acid and its relevance to fetal development? Several of the countries represented by the programmes participating in this study promulgated national policies at diVerent times during the course of this study. In some of these, studies have been undertaken to determine the extent to which their policies are being implemented. To augment this information, the directors of participating programmes were asked to undertake at least one, and preferably two, "folate awareness surveys" to determine what women of childbearing age knew about folic acid, and how many had taken steps to increase their folic acid intake, by taking vitamin pills, by changing their diet, or both, before starting a pregnancy.
Our study of time trends in NTD prevalence was based on birth registries in ICBDMS. This was founded in 1974, and links a group of birth defects registries that have reliable records of the prevalence of all major congenital anomalies in the populations they cover. Some are based on defined geographical populations, others on births in one or more hospitals. Their methodologies are not identical but do not change over time, so year on year comparisons of prevalence rates are valid.
Monitoring programmes included in this study fall into two categories: 1 Those that have data on induced abortions for NTD. 2 Those in countries where induced abortion for birth defect is illegal. Programmes in countries that permit induced abortions but that do not have access to the relevant data have been excluded. The aim of this was to limit the study to registries including all cases of NTD that would have been born if no legal induced abortions had taken place.
For the purposes of this study, NTD were defined as anencephaly and spina bifida. Cases in which the two conditions coexist are classified as anencephaly-that is, no infant or fetus is counted twice.
The time period covered was from 1 January 1988 to 30 June 1996 for live and still births. Induced abortions were recorded from 1 July 1987 to 31 December 1995 on the basis that, had they not been aborted, they would have been born, on average, about six months later. If the gestational age of an aborted fetus was known, a theoretical date of birth was calculated. Time trends were calculated from these data.
Annual time trends were analysed using a regression model. As we are interested in the relation between the number of cases per year over a period of time, allowing for possible confounding factors, the most suitable model is the Poisson regression model. 6 Using diVerent Poisson models, we estimated the average annual variation in prevalence rates 1988-96 (table 2) and the ratio between the prevalence rates in the two periods before and after 1994, when the folate policies might have begun to produce eVects (table 3) . However, such ratios do not distinguish the real eVect of the policies from the general trend of NTD occurrence. For this purpose we estimated the ratios adjusted for the eVect of long term tendency ( 
Results

INQUIRIES INTO FOLATE SUPPELMENTATION
National policies on folate supplementation for prevention of NTD Recommendations on folate supplementation for the prevention of NTD were first promulgated to the public and the health professions in the USA in September 1992, followed by England and Wales in December 1992. Similar recommendations were made in the Netherlands in November 1993. Hungary followed suit in September 1995. In Israel, a national policy was agreed but was thought not to have been implemented before the end of the study period. Up to that time, Japan, Norway, France and South America had not adopted any national policies on supplementation.
Folate awareness
The existence of a national policy on folate supplementation does not mean that it is necessarily being implemented, or to what extent. The absence of a national policy does not necessarily mean that the public and health professions are not informed about the use of folic acid to prevent NTD and are not using it for this purpose. An attempt was therefore made by most of the participating programmes to determine from representative samples of women of childbearing age (in many cases, women attending antenatal clinics) their knowledge and use of folic acid for NTD prevention.
England and Wales-A number of studies have been carried out by SutcliVe, 7 Clark and Fisk 8 and Wild. 9 These showed very low levels of awareness in the year after national recommendations had been promulgated, with a significant improvement thereafter. Three studies in the city of Leeds showed that in 1993, 11 (1.8%) of 613 women interviewed at their first antenatal clinic attendance had taken folic acid before conception. The following year this figure had risen to 110 (18.2%) of 603 comparable women. By 1996 the number had increased to 208 (30.6%) of 679 women. (Wild 1997, personal communication) France-A study in Paris in 1995, 10 showed that 68 (9.3%) of 733 women in maternity hospitals had taken folic acid before pregnancy or during the first month. In 58 of these cases (85%) the folic acid was prescribed by a doctor.
Hungary-Of 105 women interviewed in 1992, seven (6.7%) had taken multivitamins that included folic acid before conception.
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None had taken folic acid alone. It should be mentioned, however, that Hungary contributed the largest number of women of any country participating in the UK Medical Research Council study 4 on prevention of NTD recurrence, and was the location of the only randomised study of prevention of first occurrence of NTD. 5 The preventive role of folic acid was therefore very well known and had received a good deal of publicity through the media.
Netherlands-A survey of 485 women in their first pregnancies was carried out in 1994, the year after the publication of oYcial advice, and showed that four (0.8%) had taken folic acid during the recommended period. 12 Further surveys were carried out in 1995 and 1996, before and after a national campaign publicising folic acid. In 1996, 96% of well educated women had heard of folic acid, 89% before conception. The corresponding figures for less well educated women were 80% and 64%. These figures were all higher than in the 1995 survey. Folic acid had been taken for the recommended period by 32% of well educated women and 17% of less well educated women. The corresponding figures in 1995 were 10% and 2% (De Walle 1997, personal communication).
South America-A survey of 491 women was carried out in 1996 and showed that about 1% had taken folic acid in the first month of pregnancy.
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United States-A survey carried out in South Carolina in 1992-1994 14 showed that 6 (8%) of 71 women with a history of previous NTD aVected pregnancy had taken folic acid in the periconceptional period. A 1995 study in Table 1 shows the numbers of cases of NTD by programme. After adjusting the induced abortions to expected dates of birth, as explained above, the numbers of cases and rates are as shown in tables 2, 3 and 4. Secular trends are evident in some programmes before the introduction of any folate supplementation policies. Over the whole study period, for anencephaly, three programmes (England and Wales, Hungary and Japan) showed a significant fall, while South America showed a significant rise. For spina bifida, a significant fall is seen in Atlanta (USA), England and Wales, Hungary and North Netherlands, while South America again showed a rise. For all NTD, Atlanta, England and Wales, Hungary, Japan and North Netherlands all show a significant fall, South America a significant rise. There are no other significant changes in prevalence.
Significant downward trends in five programmes are shown graphically in figure 1 . In four of these programmes, the downward trend has no definable beginning or end. As is to be expected, the programmes with the largest numbers of cases (England and Wales and Japan) show the smoothest curves, and these two programmes are the only ones in which the lowest rate was recorded in the final year of the study (1996) . In Hungary, there is a downward trend from 1988 to 1992 and very little change thereafter.
In tables 5 and 6, the years covered in the study have been arbitrarily divided into two periods, 1988-1993 and 1994-1996 . These correspond very approximately to periods (1) when supplementation policies could not be expected to have had any significant influence, and (2) when an eVect could have been seen in countries that were the first to promulgate policies. Table 5 is a crude comparison. It shows a significant fall in prevalence rates for all NTD from the first to the second period in Atlanta (USA), England and Wales, Hungary and Japan, and a significant rise in Norway and South America. In table 6, the figures have been adjusted to allow for the secular trends observed in the earlier years of the study. The significant trends seen in table 5 are no longer evident apart from the increase in Norway, attributable to an increase in spina bifida.
However, there is no significant change in NTD rates in Norway over the whole study period. In 1994 and 1995 (both included in the second period) the rates for both anencephaly and spina bifida were rather higher than usual but fell again in 1996. The rise in rates between the two periods is probably a chance event. For a better evaluation of the results table 6 reports the statistical power for detecting a 25% variation between the two periods with a two tailed of 0.05. The large sample size allows for a high level of statistical power, but for small registries.
Discussion
The statistically significant falls and rises in NTD prevalence rates from January 1988 to mid-1996 seem to represent continuing secular trends, decreasing in the USA (Atlanta), England and Wales, Hungary, Japan and the Netherlands, and increasing in South America. There is a rough association between significantly falling incidence rates and the early promulgation of recommendations, but it seems unlikely that the recommendations have caused the fall. It seems more probable that more aZuent countries experience falling NTD rates and can aVord to allocate resources to folate supplementation programmes, while the reverse is true in poor countries. At one time, the British Isles (United Kingdom and Republic of Ireland) had the unenviable reputation of having the highest NTD rates in the world. This distinction now belongs to South and Central America, where poverty coincides with the illegality of pregnancy termination.
There is no convincing evidence that, up to the middle of 1996, any change was attributable to the introduction of national folate supplementation policies. Even in England and Wales, the rate adjusted for secular trend did not decrease significantly between 1988-93 and 1994-96, although the power estimates in table 6 suggest that such a decrease might well have occurred if the uptake of folic acid before conception for the whole county had matched the Leeds figures (18%-31% for 1994-96). It is clear that, where supplementation policies have been promulgated, they take a very long time and a great deal of eVort to implement. The possible eVectiveness of folate supplementation for the reduction of NTD clearly needs to be tried and studied for several more years. However, recognising that, in the Western 
KEY POINTS
+ Many studies confirm that folic acid supplements could prevent most NTDs. + Public health policies relating to folic acid supplementation have been adopted by health authorities in many countries. + The existence of a national policy does not necessarily imply that it is being implemented. + The frequency of NTD up to mid-1996 seems not to have been influenced by folate supplements.
world at least, approximately 50% of pregnancies are unplanned, a policy that rests on action taken before conception can only have limited success. The alternative of fortifying staple foods by adding folic acid to cereal flours, which was mandatory in the USA with eVect from 1 January 1998, may prove to be a more successful strategy, provided that the level of enrichment is suYcient.
